By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Akashi Therapeutics (Formerly Known As Dart Therapeutics) 

20 Stockbridge Road Suite 3

Gt Barrington  Massachusetts   01230  U.S.A.
Phone: n/a Fax: n/a



Company News
Akashi Therapeutics Acquires Global Rights To Novel DMD Treatment From Tonus Therapeutics 9/15/2014 7:36:19 AM
Akashi Therapeutics Presents Positive Clinical Data On HT-100 In Patients With Duchenne Muscular Dystrophy 7/3/2014 6:06:50 AM
Akashi Therapeutics Receives Collective Funding Of $1.5 Million To Support HT-100 Clinical Development 7/3/2014 6:03:32 AM
Dart Therapeutics Changes Name To Akashi Therapeutics 6/24/2014 10:27:08 AM
Dart Therapeutics Initiates Study of HT-100 for Duchenne Muscular Dystrophy 7/15/2013 11:11:58 AM
Biovista and Dart Therapeutics Enter into Drug Repositioning Collaboration Targeting Duchenne Muscular Dystrophy 3/26/2013 9:54:37 AM
Dart Therapeutics Develops Drug Candidate for Duchenne Muscular Dystrophy 3/20/2013 9:31:26 AM
Dart Therapeutics Completes Study of New Biomarker for Duchenne Muscular Dystrophy 10/10/2012 10:15:14 AM
Dart Therapeutics Appoints Executive Team 9/10/2012 9:35:20 AM
Two Families Facing DMD Launches Biotech Start-up Dart Therapeutics 12/28/2011 8:21:31 AM